Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Skye Bioscience (SKYE) just unveiled an announcement.
Skye Bioscience, Inc. has appointed Dr. Puneet S. Arora as their new Chief Medical Officer, bringing a wealth of experience from his previous roles in clinical development, regulatory affairs, and as an executive leader in various biotechnology firms. Dr. Arora’s impressive credentials include leadership positions at Amira Advisors, Lassen Therapeutics, Principia Biopharma, and Genentech, as well as a strong academic background with a medical degree and several specialized fellowships. His employment agreement details a generous salary, performance bonuses, and severance terms, alongside an enticing stock option plan as part of his compensation package.
See more insights into SKYE stock on TipRanks’ Stock Analysis page.
